Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adjuvant chemotherapy)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Grothey, A; Sobrero, A; Meyerhardt, JA; Yoshino, T; Paul, J; Taieb, J; Souglakos, I; Kerr, R; Labianca, R; Shields, AF; Bonnetain, F; Yamanaka, T; Boukovinas, I; Shi, Q; Meyers, JP; Niedzwiecki, D; Torri, V; Sargent, DJ; Andre, T; Iveson, T

Published Date

  • September 1, 2017

Published In

Volume / Issue

  • 28 /

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference Location

  • Madrid, SPAIN

Conference Start Date

  • September 8, 2017

Conference End Date

  • September 12, 2017